601089 福元醫藥
按盤價 
16.980 +1.140 (+7.197%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 8.493 | 14.716 | 20.014 | 28.372 | 28.353 |
| 總資產報酬率 ROA (%) | 6.469 | 11.021 | 13.556 | 16.310 | 15.346 |
| 投入資產回報率 ROIC (%) | 8.044 | 13.870 | 18.263 | 24.766 | 22.906 | 邊際利潤分析 |
| 銷售毛利率 (%) | 66.693 | 66.635 | 68.234 | 69.507 | 71.081 |
| 營業利潤率 (%) | 19.272 | 16.529 | 14.709 | 12.701 | 12.197 |
| 息稅前利潤/營業總收入 (%) | 17.610 | 14.925 | 14.120 | 13.028 | 12.155 |
| 淨利潤/營業總收入 (%) | 17.665 | 14.742 | 13.568 | 11.133 | 10.433 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 92.057 | 97.223 | 97.099 | 97.920 | 97.528 |
| 價值變動淨收益/利潤總額(%) | -0.095 | 0.332 | 0.573 | 0.584 | 0.788 |
| 營業外收支淨額/利潤總額(%) | -0.133 | -0.521 | 1.922 | 1.443 | -3.156 | 償債能力分析 |
| 流動比率 (X) | 3.131 | 3.334 | 3.203 | 1.477 | 1.568 |
| 速動比率 (X) | 2.790 | 3.026 | 2.881 | 1.103 | 1.163 |
| 資產負債率 (%) | 23.704 | 23.555 | 26.447 | 43.557 | 40.830 |
| 帶息債務/全部投入資本 (%) | 4.074 | 3.335 | 4.417 | 9.482 | 10.147 |
| 股東權益/帶息債務 (%) | 2,317.206 | 2,848.478 | 2,115.690 | 906.669 | 876.403 |
| 股東權益/負債合計 (%) | 320.920 | 323.772 | 277.724 | 129.177 | 144.573 |
| 利息保障倍數 (X) | -10.764 | -9.830 | -16.094 | 92.512 | 36.720 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 37.529 | 40.025 | 40.801 | 45.223 | 55.953 |
| 存貨周轉天數 (天) | 105.029 | 104.438 | 115.964 | 125.010 | 133.231 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
